Congratulations to the research team of the Mahjoub Laboratory, who are celebrating their multiple recent publications, one of which landed the cover of the journal JCI Insight.
The WashU Nephrology laboratory, headed by Moe Mahjoub, PhD, focuses on defining the roles of centrosome-cilium complex during kidney development and homeostasis. These signaling hubs regulate key aspects of cell division, differentiation, and fate. Defects in the structure or function of these organelles lead to a range of human diseases known collectively as “ciliopathies,” which include polycystic and fibrotic kidney diseases, among others.
The lab’s most recent publication is “Inhibiting centrosome clustering reduces cystogenesis and improves kidney function in autosomal dominant polycystic kidney disease (ADPKD).” The article was featured on the cover of JCI Insight (Feb 2024, vol 9, issue 4) with an image credited to postdoctoral fellow and co-author Ewa Langner, PhD. The researchers explored therapeutic strategies for ADPKD and found that inhibiting centrosome clustering using specific inhibitors reduced cyst formation, improved kidney function, and decreased interstitial fibrosis. Their approach represents a promising target for treating ADPKD. Authors: Tao Cheng, Aruljothi Mariappan, Ewa Langner, Kyuhwan Shim, Jay Gopalakrishnan, and Moe R Mahjoub.
In a second article, “Cep120 is essential for kidney stromal progenitor cell growth and differentiation,” published in EMBO Reports (Jan 2024, Vol 24, No 1), they investigated the cellular and developmental defects caused by loss of Cep120 and aberrant centrosome biogenesis in the embryonic kidney stroma. Loss of Cep120 in renal stromal progenitors disrupts centrosome biogenesis, growth and fate of interstitial cells, resulting in hypoplastic kidneys. Defective centrosome formation also sensitizes the developed kidneys, causing rapid fibrosis after injury. Authors: Ewa Langner, Tao Cheng, Eirini Kefaloyianni, Charles Gluck, Baolin Wang and Moe R Mahjoub.
In their third publication titled “Aberrant centrosome biogenesis disrupts nephron and collecting duct progenitor growth and fate resulting in fibrocystic kidney disease,” published in Development (Dec 2023; vol 150, issue 24), they investigated the impact of centrosome dysfunction on kidney development. They found that loss of the ciliopathy gene Cep120 disrupted nephron and collecting duct progenitor growth, leading to fibrocystic kidney disease. The study highlights the critical role of centrosomes in kidney morphogenesis and identifies new therapeutic targets for renal centrosomopathies. Authors: Tao Cheng, Chidera Agwu, Kyuhwan Shim, Baolin Wang, Sanjay Jain and Moe R. Mahjoub.
On X, follow @MahjoubLab, @ChengTao_PKD, @LangnerEP and @WUNephrology; visit and “Like” us on Facebook.